Funnelfeedr Logo

Disruptive Pharma AB (publ)

Sweden556755-3226Active

Swedish biotech developing novel kidney disease therapies based on proprietary peptides.

Biotechnology Companyguardtherapeutics.com

Overview

5–9
Employees
≤1K SEK
Revenue
2008
Founded

Key Decision Makers

Tobias L Agervald

CEO

@guardtherapeutics.com+46867XXXXX

Karin Botha

CFO

Khatereh Ahmadi

Board Member

Torbjörn Larsson

Head of Chemistry, Manufacturing and Control

+9 more contacts in Funnelfeedr

Description

Guard Therapeutics is a Swedish clinical-stage biotechnology company dedicated to developing novel therapies for kidney diseases, addressing significant unmet medical needs. The company's drug candidates are uniquely based on the body's own protein, alpha-1-microglobulin. Their lead candidate, RMC-0...

Tags

B2BHealthcarePharmaceuticalsProfessional ServicesPublicly ListedTechnologyWhite Collar

Keywords

BiotechnologyClinical StageDrug DevelopmentKidney DiseasePharmaRMC-035

Tech Stack

YiijQueryVimeoBootstrapCraft CMSFont AwesomeModernizrPHP

Company Information

Industry
Annan naturvetenskaplig och teknisk forskning och utveckling
Legal Form
Aktiebolag
VAT Number
SE556755322601

Decision Makers

13 contacts in Funnelfeedr

Tobias L Agervald

CEO

@guardtherapeutics.com+46867XXXXX

Karin Botha

CFO

Khatereh Ahmadi

Board Member

Torbjörn Larsson

Head of Chemistry, Manufacturing and Control

Sara Thuresson

Head of Clinical Operations

Fredrik Lehmann

Board Member

Göran Forsberg

Board Member

Johannes Hulthe

Board Member

Michael Reusch

CMO

Johan Bygge

Chairman of the Board

Hege Hellström

Board Member

Peter Gilmour

Head of Preclinical Science

Other Contacts

Mikael Widell

IR Contact

@guardtherapeutics.com

Similar Companies

20 similar companies in Funnelfeedr

Browse More

Disruptive Pharma AB (publ) Questions

Want to see Funnelfeedr in action?

Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.

Book a demo